Literature DB >> 9551823

Measurement of serum nitrite/nitrate concentrations using high-performance liquid chromatography.

I El Menyawi1, S Looareesuwan, S Knapp, F Thalhammer, B Stoiser, H Burgmann.   

Abstract

Previous studies have reported increased serum concentrations of nitrite/nitrate - the degradation products of nitric oxide - in Plasmodium vivax malaria and uncomplicated Plasmodium falciparum malaria. In all these studies, however, nitrite/nitrate has been measured spectrometrically using Griess reagent which carries major disadvantages in the determination of serum nitrite/nitrate. The method does not allow an exact differentiation of nitrite and biogenic amines that are physiologically present in plasma. In the present study we introduce high-performance liquid chromatography as a new, accurate and cost effective method for determination of serum nitrite/nitrate levels. Significantly increased nitrate concentrations were found in malaria patients and serum values remained above normal levels for at least 21 days. It could be shown that our HPLC method is a sensitive and cost-effective method for direct determination of nitrite/nitrate in serum samples, which is not influenced by the presence of biogenic amines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551823     DOI: 10.1016/s0378-4347(97)00570-7

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  2 in total

1.  Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome.

Authors:  B Stoiser; F Thalhammer; I El-Menyawi; A Wilfing; F Daxböck; G J Locker; H Burgmann
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Determination of nitric oxide metabolites, nitrate and nitrite, in Anopheles culicifacies mosquito midgut and haemolymph by anion exchange high-performance liquid chromatography: plausible mechanism of refractoriness.

Authors:  Arun Sharma; Kamaraju Raghavendra; Tridibesh Adak; Aditya P Dash
Journal:  Malar J       Date:  2008-04-28       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.